Amneal Accounts Payable from 2010 to 2025

AMRX Stock  USD 8.58  0.32  3.87%   
Amneal Pharmaceuticals, Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Amneal Pharmaceuticals, Class owes to suppliers or vendors for products or services received but not yet paid for. It represents Amneal Pharmaceuticals,'s short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2016-12-31
Previous Quarter
201.8 M
Current Value
235 M
Quarterly Volatility
207.3 M
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 254.3 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.096 or PTB Ratio of 50.74. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Amneal Pharmaceuticals, Class over the last few years. An accounting item on the balance sheet that represents Amneal Pharmaceuticals, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Amneal Pharmaceuticals, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Amneal Pharmaceuticals,'s Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Amneal Accounts Payable Regression Statistics

Arithmetic Mean159,777,133
Geometric Mean121,685,231
Coefficient Of Variation91.15
Mean Deviation97,168,683
Median132,866,999
Standard Deviation145,634,565
Sample Variance21209.4T
Range454.4M
R-Value0.38
Mean Square Error19484.2T
R-Squared0.14
Significance0.15
Slope11,550,745
Total Sum of Squares318141.4T

Amneal Accounts Payable History

2025222.4 M
2024165.1 M
2023143.6 M
2022166.8 M
2021132.9 M
2020154.1 M
2019507.5 M

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable165.1 M222.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.